LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 63 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $38,000 | -75.9% | 139,105 | -69.2% | 0.00% | -100.0% |
| Q2 2022 | $158,000 | -48.5% | 451,478 | 0.0% | 0.00% | -50.0% |
| Q1 2022 | $307,000 | -70.6% | 451,478 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $1,043,000 | -49.6% | 451,478 | 0.0% | 0.01% | -44.4% |
| Q3 2021 | $2,068,000 | +3.1% | 451,478 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $2,005,000 | -39.0% | 451,478 | 0.0% | 0.01% | -35.7% |
| Q1 2021 | $3,287,000 | -4.6% | 451,478 | 0.0% | 0.01% | +7.7% |
| Q4 2020 | $3,445,000 | – | 451,478 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 500,000 | $2,220,000 | 0.38% |
| Orbimed Advisors | 8,466,783 | $37,593,000 | 0.38% |
| Sio Capital Management, LLC | 182,630 | $811,000 | 0.20% |
| Tibra Equities Europe Ltd | 76,500 | $340,000 | 0.10% |
| SAMLYN CAPITAL, LLC | 1,420,452 | $6,308,000 | 0.09% |
| PURA VIDA INVESTMENTS, LLC | 249,256 | $1,107,000 | 0.03% |
| Trexquant Investment LP | 46,229 | $205,000 | 0.02% |
| SANDERS MORRIS HARRIS LLC | 15,000 | $67,000 | 0.01% |
| Baker Brothers Advisors | 451,478 | $2,005,000 | 0.01% |
| Verition Fund Management LLC | 208,099 | $924,000 | 0.01% |